The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications submitted to the agency from 2020 to 2024.This article […]
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson’s disease, potentially replacing the need for multiple daily tablets.This article was originally published on MedicalXpress.com
Receiving six or more prescriptions of the drug gabapentin for low back pain is associated with significantly increased risks of developing dementia and mild cognitive impairment (MCI)—29% and 85%, respectively—finds a large medical records study […]
Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, published in the Journal of Medical Virology, demonstrate […]
As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research raises important concerns about their use among adolescent boys and young men.This article was originally published […]
Australia’s drug approval system is under fire, with critics in the United States claiming it is too slow to approve life-saving medicines.This article was originally published on MedicalXpress.com
You might have heard cannabis and cannabinoid products can help people sleep. Data shows one of the top reasons people use cannabis is to help them sleep.This article was originally published on MedicalXpress.com
After nearly 15 years’ research, scientists at the UdeM-affiliated CHU Sainte-Justine have developed a compound that has shown remarkable potential in preventing prematurity in mice.This article was originally published on MedicalXpress.com
The largest review of “gold standard” antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced by people discontinuing antidepressants, finding most people do not experience severe withdrawal.This article was originally […]
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with the potential to replace this current cornerstone in the treatment of drug-resistant TB.This article was […]
© 2025 SimplyWell.ca